Crossmark

Efficacy and safety of mRNA1273 SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Single center experience

Crossref DOI link: https://doi.org/10.1016/j.medcli.2023.10.016

Published Print: 2024-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Huguet, Maria

Boigues, Marc

Sorigué, Marc

Blanco, Julià

Quirant, Bibiana

Ferrà, Christelle

Huguet, Maria

Boigues, Marc

Morgades, Mireia

Felip, Eudald

Morán, Teresa

Pradenas, Edwards

Marfil, Silvia

Trinité, Benjamin

Sorigué, Marc

Torrent, Anna

Abril, Laura

Blanco, Julià

Sancho, Juan-Manuel

Quirant, Bibiana

Ferrà, Christelle
License Information

Text and Data Mining valid from 2024-04-01

stm-asf valid from 2024-04-01

stm-asf valid from 2024-04-01

stm-asf valid from 2024-04-01

stm-asf valid from 2024-04-01

stm-asf valid from 2024-04-01
More Information

This article is maintained by: Elsevier

Article Title: Efficacy and safety of mRNA1273 SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Single center experience

Journal Title: Medicina Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2023.10.016

Content Type: article

Copyright: © 2023 Elsevier España, S.L.U. All rights reserved.